NeuroVive Pharmaceutical AB Float d'actions
Quel est le Float d'actions de NeuroVive Pharmaceutical AB?
Le Float d'actions de NeuroVive Pharmaceutical AB est 272.606M 67.64%
Quelle est la définition de Float d'actions ?
Le flottant des actions est la partie des actions d’une société qui est entre les mains d’investisseurs publics, par opposition aux actions immobilisées.
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Float d'actions des entreprises dans Health Care secteur sur OTC par rapport à NeuroVive Pharmaceutical AB
Que fait NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Entreprises avec float d'actions similaire à NeuroVive Pharmaceutical AB
- Cyrela Brazil Realty SA Empreendimentos e Participações a Float d'actions de 272.257M 70.81%
- Ningbo Ronbay New Technology Co a Float d'actions de 272.333M 61.44%
- Fitbit a Float d'actions de 272.335M 109.58%
- Fitbit A Dl ,0001 a Float d'actions de 272.335M 111.22%
- Swiss Re AG a Float d'actions de 272.468M 88.78%
- BeijingWest Industries International a Float d'actions de 272.495M 47.45%
- NeuroVive Pharmaceutical AB a Float d'actions de 272.606M 67.64%
- Foxtons Plc a Float d'actions de 272.908M 85.56%
- NN NV a Float d'actions de 272.918M 96.59%
- Engineers India a Float d'actions de 272.932M 48.56%
- Intuit a Float d'actions de 272.978M 106.77%
- Royal BAM Groep NV a Float d'actions de 273.032M 99.90%
- Forebase International a Float d'actions de 273.219M 25.00%